As of May 31, 2025, MannKind Corp (MNKD) reports a Graham Number of 2.44.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of MannKind Corp's Graham Number
Over recent years, MannKind Corp's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 2.44 |
| 2023-12-31 | 2.44 |
This trend highlights how MannKind Corp manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing MannKind Corp's Graham Number to Peers
To better understand MannKind Corp's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| MannKind Corp (MNKD) | 2.44 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Oncology Pharma Inc (ONPH) | 77.95 |
| Amgen Inc (AMGN) | 43.25 |
Compared to its competitors, MannKind Corp's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.